Literature DB >> 33407541

Preparing the healthcare workforce in South Africa for short-course rifampicin-resistant TB treatment: inter-professional training and task-sharing considerations.

Jason E Farley1, Norbert Ndjeka2, Khaya Mlandu3, Kelly Lowensen3, Keri Geiger3, Yen Nguyen3, Chakra Budhathoki3, Paul D Stamper3.   

Abstract

BACKGROUND: Treatment for rifampicin-resistant Mycobacterium tuberculosis (RR-TB) is complex, however, shorter treatment, with newer antimicrobials are improving treatment outcomes. The South African National Department of Health (NDoH) recently accelerated the rollout of 9-month, all-oral, RR-TB short-course regimens. We sought to evaluate an inter-professional training program using pre-test and post-test performance of Professional Nurses (PNs), Advanced Practice Professional Nurses (APPNs) and Medical Officers (MOs) to inform: (a) training needs across cadres; (b) knowledge performance, by cadres; and (c) training differences in knowledge by nurse type.
METHODS: A 4-day didactic and case-based clinical decision support course for RR-TB regimens in South Africa (SA) was developed, reviewed and nationally accredited. Between February 2017 and July 2018, 12 training events were held. Clinicians who may initiate RR-TB treatment, specifically MOs and PN/APPNs with matched pre-post tests and demographic surveys were analyzed. Descriptive statistics are provided. Pre-post test evaluations included 25 evidence-based clinically related questions about RR-TB diagnosis, treatment, and care.
RESULTS: Participants (N = 842) participated in testing, and matched evaluations were received for 800 (95.0%) training participants. Demographic data were available for 793 (99.13%) participants, of whom 762 (96.1%) were MOs, or nurses, either PN or APPNs. Average correct response pre-test and post-test scores were 61.7% (range 7-24 correct responses) and 85.9% (range 12-25), respectively. Overall, 95.8% (730/762) of participants demonstrated improved knowledge. PNs improved on average 25% (6.22 points), whereas MOs improved 10% (2.89 points) with better mean test scores on both pre- and post-test (p < 0.000). APPNs performed the same as the MOs on post-test scores (p = NS).
CONCLUSIONS: The inter-professional training program in short-course RR-TB treatment improved knowledge for participants. MOs had significantly greater pre-test scores. Of the nurses, APPNs outperformed other PNs, and performed equally to MOs on post-test scores, suggesting this advanced cadre of nurses might be the most appropriate to initiate and monitor treatment in close collaboration with MOs. All cadres of nurse reported the need for additional clinical training and mentoring prior to managing such patients.

Entities:  

Keywords:  Clinical; Multidrug-resistant; Nurse practitioner; Primary health care; Rifampicin-resistant; South Africa; Tuberculosis

Year:  2021        PMID: 33407541     DOI: 10.1186/s12960-020-00552-1

Source DB:  PubMed          Journal:  Hum Resour Health        ISSN: 1478-4491


  6 in total

1.  Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidence.

Authors:  Emanuele Pontali; Giovanni Sotgiu; Lia D'Ambrosio; Rosella Centis; Giovanni Battista Migliori
Journal:  Eur Respir J       Date:  2016-02       Impact factor: 16.671

Review 2.  Evaluating the impact of healthcare provider training to improve tuberculosis management: a systematic review of methods and outcome indicators used.

Authors:  Shishi Wu; Imara Roychowdhury; Mishal Khan
Journal:  Int J Infect Dis       Date:  2016-12-12       Impact factor: 3.623

3.  Antiretroviral switching and bedaquiline treatment of drug-resistant tuberculosis HIV co-infection.

Authors:  Max R O'Donnell; Nesri Padayatchi; Amrita Daftary; Catherine Orrell; Kelly E Dooley; K Rivet Amico; Gerald Friedland
Journal:  Lancet HIV       Date:  2019-03       Impact factor: 12.767

4.  Re-inventing adherence: toward a patient-centered model of care for drug-resistant tuberculosis and HIV.

Authors:  M R O'Donnell; A Daftary; M Frick; Y Hirsch-Moverman; K R Amico; M Senthilingam; A Wolf; J Z Metcalfe; P Isaakidis; J L Davis; J R Zelnick; J C M Brust; N Naidu; M Garretson; D R Bangsberg; N Padayatchi; G Friedland
Journal:  Int J Tuberc Lung Dis       Date:  2016-04       Impact factor: 2.373

5.  Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis: a retrospective cohort study.

Authors:  Kathryn Schnippel; Norbert Ndjeka; Gary Maartens; Graeme Meintjes; Iqbal Master; Nazir Ismail; Jennifer Hughes; Hannetjie Ferreira; Xavier Padanilam; Rodolfo Romero; Julian Te Riele; Francesca Conradie
Journal:  Lancet Respir Med       Date:  2018-07-11       Impact factor: 30.700

6.  Digital health to end tuberculosis in the Sustainable Development Goals era: achievements, evidence and future perspectives.

Authors:  Dennis Falzon; Giovanni Battista Migliori; Ernesto Jaramillo; Karin Weyer; Guy Joos; Mario Raviglione
Journal:  Eur Respir J       Date:  2017-11-09       Impact factor: 16.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.